1. Home
  2. LQDT vs MRVI Comparison

LQDT vs MRVI Comparison

Compare LQDT & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LQDT
  • MRVI
  • Stock Information
  • Founded
  • LQDT 1999
  • MRVI 2020
  • Country
  • LQDT United States
  • MRVI United States
  • Employees
  • LQDT N/A
  • MRVI N/A
  • Industry
  • LQDT Catalog/Specialty Distribution
  • MRVI Biotechnology: Pharmaceutical Preparations
  • Sector
  • LQDT Consumer Discretionary
  • MRVI Health Care
  • Exchange
  • LQDT Nasdaq
  • MRVI Nasdaq
  • Market Cap
  • LQDT 975.1M
  • MRVI 809.2M
  • IPO Year
  • LQDT 2006
  • MRVI 2020
  • Fundamental
  • Price
  • LQDT $34.56
  • MRVI $4.77
  • Analyst Decision
  • LQDT Strong Buy
  • MRVI Buy
  • Analyst Count
  • LQDT 2
  • MRVI 10
  • Target Price
  • LQDT $38.50
  • MRVI $10.28
  • AVG Volume (30 Days)
  • LQDT 275.5K
  • MRVI 1.8M
  • Earning Date
  • LQDT 02-06-2025
  • MRVI 02-25-2025
  • Dividend Yield
  • LQDT N/A
  • MRVI N/A
  • EPS Growth
  • LQDT N/A
  • MRVI N/A
  • EPS
  • LQDT 0.63
  • MRVI N/A
  • Revenue
  • LQDT $363,318,000.00
  • MRVI $276,920,000.00
  • Revenue This Year
  • LQDT $31.09
  • MRVI N/A
  • Revenue Next Year
  • LQDT N/A
  • MRVI $2.25
  • P/E Ratio
  • LQDT $54.86
  • MRVI N/A
  • Revenue Growth
  • LQDT 15.54
  • MRVI N/A
  • 52 Week Low
  • LQDT $13.99
  • MRVI $4.28
  • 52 Week High
  • LQDT $36.11
  • MRVI $11.56
  • Technical
  • Relative Strength Index (RSI)
  • LQDT 64.26
  • MRVI 39.85
  • Support Level
  • LQDT $32.15
  • MRVI $4.38
  • Resistance Level
  • LQDT $36.11
  • MRVI $6.21
  • Average True Range (ATR)
  • LQDT 1.12
  • MRVI 0.39
  • MACD
  • LQDT -0.04
  • MRVI -0.09
  • Stochastic Oscillator
  • LQDT 69.49
  • MRVI 21.31

About LQDT Liquidity Services Inc.

Liquidity Services Inc is an online auction marketplace. It manages and sells inventory and equipment for business and government clients by operating a network of e-commerce marketplaces that enable buyers and sellers to transact in an efficient, automated environment offering across different product categories. The company has four reportable segments: GovDeals, Capital Assets Group (CAG), Retail Supply Chain Group (RSCG), and Machinio. It generates majority of its revenue from Retail Supply Chain Group (RSCG) segment which consists of marketplaces that enable corporations located in the United States and Canada to sell excess, returned, and overstocked consumer goods. Geographically, a substantial portion the company's revenue is generated from its business in United States.

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company. It provides products to enable the development of drug therapies, diagnostics, and novel vaccines and supports research on human diseases. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

Share on Social Networks: